Skip to content
HowShorted

SkinHealth Systems Inc. Class short interest in 2024

In 2024, SkinHealth Systems Inc. Class's disclosed short interest ran from 9.42% of shares outstanding on 12 Jan 2024 to 6.61% on 31 Dec 2024, a change of -2.81 percentage points. The year's high was 10.74% on 31 Jan 2024 and its low 6.09% on 15 Nov 2024, averaging 7.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.54 days on 13 Dec 2024. Full history: SkinHealth Systems Inc. Class.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SkinHealth Systems Inc. Class in 2024

2024 in figures

Start of year
9.42% (12 Jan 2024)
End of year
6.61% (31 Dec 2024)
Change
-2.81 pp
High
10.74% (31 Jan 2024)
Low
6.09% (15 Nov 2024)
Average
7.99%
Highest days to cover
14.54 (13 Dec 2024)
SEC filings marked
8

Every report in 2024

SkinHealth Systems Inc. Class short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20249.42%4.67
31 Jan 202410.74%5.28
15 Feb 202410.03%6.86
29 Feb 20249.70%4.17
15 Mar 20249.72%2.7210-K filed, results (8-K)
28 Mar 20248.73%4.49
15 Apr 20248.32%6.29
30 Apr 20248.02%7.33
15 May 20248.01%4.6410-Q filed, results (8-K)
31 May 20248.08%8.68
14 Jun 20248.00%5.65
28 Jun 20247.90%4.91
15 Jul 20247.30%6.94
31 Jul 20247.33%7.96
15 Aug 20246.80%2.5510-Q filed, results (8-K)
30 Aug 20248.30%7.23
13 Sep 20247.47%9.25
30 Sep 20247.89%11.12
15 Oct 20247.81%9.98
31 Oct 20246.86%13.42
15 Nov 20246.09%6.1710-Q filed, results (8-K)
29 Nov 20246.59%12.71
13 Dec 20246.14%14.54
31 Dec 20246.61%13.89

See also: SkinHealth Systems Inc. Class's full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.